Lv1
32 积分 2024-09-08 加入
Symptom burden and quality of life in patients with high-risk essential thrombocythaemia and polycythaemia vera receiving hydroxyurea or pegylated interferon alfa-2a: a post-hoc analysis of the MPN-RC 111 and 112 trials
20天前
已完结
Ropeginterferon alfa-2b in hydroxyurea-intolerant or hydroxyurea-refractory essential thrombocythaemia (SURPASS ET): a multicentre, open-label, randomised, active-controlled, phase 3 study
20天前
已完结
All-trans retinoic acid plus high-dose dexamethasone as first-line treatment for patients with newly diagnosed immune thrombocytopenia: a multicentre, open-label, randomised, controlled, phase 2 trial
20天前
已完结
Platinum-containing regimens for triple-negative metastatic breast cancer
1个月前
已完结
Efficacy and safety of interleukin-6 receptor inhibitors in myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD): A systematic review and meta-analysis
1个月前
已完结
HDAC3 activates endothelial NLRP3 inflammasome and promotes atherosclerosis via inhibiting the acetylation of specificity protein 1
1个月前
已完结
Model-Informed Drug Development Applications and Opportunities in mRNA-LNP Therapeutics
2个月前
已完结
β-Cyclodextrin metal-organic framework as a green carrier to improve the dissolution, bioavailability, and liver protective effect of luteolin
2个月前
已完结
皖公网安备34019202002308
